Effects of Catheter Ablation on Burden of Atrial Fibrillation (MRICEMAN)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.
Also called NCT02639793
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT02639793
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Finland
- Registry status
- Unknown status
Technical summary
Registry record NCT02639793. Randomized; single masking; primary purpose treatment. Start 2016-01 (registry gives no type); primary completion 2019-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Catheter Ablation on Burden of Atrial Fibrillation (MRICEMAN)
- Acronym
- MRICEMAN
- Condition
- Atrial Fibrillation
- Intervention (Procedure)
- catheter ablation
- Lead sponsor
- Heikki Huikuri
- Collaborator
- University of Helsinki
Record details
- Record id
cardio:ct-nct02639793- Content hash
94b45f6e660a625f115c56d99be49b5022f7be4a0c4195627ac12048dde60909